N-Boc-Nortropinone

Modify Date: 2025-08-26 22:35:52

N-Boc-Nortropinone Structure
N-Boc-Nortropinone structure
Common Name N-Boc-Nortropinone
CAS Number 185099-67-6 Molecular Weight 225.284
Density 1.1±0.1 g/cm3 Boiling Point 325.8±35.0 °C at 760 mmHg
Molecular Formula C12H19NO3 Melting Point 70-74 °C
MSDS USA Flash Point 150.8±25.9 °C
Symbol GHS05
GHS05
Signal Word Danger

 Names

Name tert-butyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 325.8±35.0 °C at 760 mmHg
Melting Point 70-74 °C
Molecular Formula C12H19NO3
Molecular Weight 225.284
Flash Point 150.8±25.9 °C
Exact Mass 225.136490
PSA 46.61000
LogP 0.80
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.507
Storage condition Store at 0-5°C

 Safety Information

Symbol GHS05
GHS05
Signal Word Danger
Hazard Statements H318
Precautionary Statements P280-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi:Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S39
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2933990090

 Synthetic Route

~95%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: Gong, Leyi; Hogg, J. Heather; Collier, James; Wilhelm, Robert S.; Soderberg, Carol Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 20 p. 3597 - 3600

~%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: US2006/100426 A1, ; Page/Page column 18 ; US 20060100426 A1

~99%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: Roche Palo Alto LLC Patent: US2009/318493 A1, 2009 ; Location in patent: Page/Page column 41-42 ; US 20090318493 A1

~83%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: Pfizer Inc. Patent: US2002/119961 A1, 2002 ;

~73%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: Bezencon, Olivier; Bur, Daniel; Corminboeuf, Olivier; Dube, Daniel; Grisostomi, Corinna; MacDonald, Dwight; McKay, Dan; Powell, David; Remen, Lubos; Richard-Bildstein, Sylvia; Scheigetz, John; Therien, Michel; Weller, Thomas Patent: US2009/176823 A1, 2009 ; Location in patent: Page/Page column 28 ;

~75%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: ACTELION PHARMACEUTICALS LTD Patent: WO2007/88514 A1, 2007 ; Location in patent: Page/Page column 75-76 ; WO 2007/088514 A1

~%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: US2007/167442 A1, ; Page/Page column 45 ;

~%

N-Boc-Nortropinone Structure

N-Boc-Nortropinone

CAS#:185099-67-6

Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 21 p. 5281 - 5284

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles1

More Articles
Ghosh S, et al.

Can. J. Chem. 84(4) , 555-560, (2006)

 Synonyms

2-Methyl-2-propanyl (1R,5S)-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate
N-(tert-Butoxycarbonyl)nortropinone
N-Boc-nortropinone
MFCD00673779
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-oxo-, 1,1-dimethylethyl ester, (1R,5S)-
2-Methyl-2-propanyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate
tert-butyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-oxo-, 1,1-dimethylethyl ester
8-Boc-3-oxo-8-azabicyclo[3.2.1]octane
N-Boc-4-Nortropinone
N-(tert-Butoxycarbonyl)-8-azabicyclo[3.2.1]octan-3-one
Boc-nortropinone
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

N-Boc-Nortropinone suppliers

N-Boc-Nortropinone price

Related Compounds: More...
N-Boc-4-cyclopropylpiperidine-4-carboxylic Acid
1346599-08-3
N-Boc-4-Oxo-D-proline
364077-84-9
N-Boc N,O-Didesmethylvenlafaxine
1076199-24-0
N-BOC-3-(4-FLUOROBENZYL)PIPERIDINE
382637-45-8
N-Boc, N-methylaminoacetone
532410-39-2
N-Boc-trans-3-hydroxy-D-proline
335280-19-8
N-BOC-(R)-1-AMINO-2-PROPANOL
119768-44-4
N-Boc-N-methoxy-N-methyl-L-phenyl-alaninamide-d5
1217640-14-6
N-BOC-3,5-DIFLUORO-D-TYROSINE
1213198-51-6
Ferrate(1-a)a, bis[4-a[[5-achloro-a2-a(hydroxy-akappaO)aphenyl]aazo-akappaN1]a-a2,a4-adihydro-a5-amethyl-a2-aphenyl-a3H-apyrazol-a3-aonato(2-a)a-akappaO3]a-
732244-72-3
(Z)-N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R)-5-acetamido-1,2,4-trihydroxy-6-oxohexan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]octadec-11-enamide
168843-28-5
5-Acetamido-4-hydroxy-3-[(2-hydroxy-5-{[2-(sulfooxy)ethyl]sulfonyl}phenyl)diazenyl]-4a,8a-dihydro-2,7-naphthalenedisulfonic acid
1098339-23-1
Trisodium 5-acetamido-4-hydroxy-3-[(2-hydroxy-5-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-4a,8a-dihydro-2,7-naphthalenedisulfonate
1098165-12-8
Cobalt(3+) sodium 4-(3-methyl-4-((4-(((3-((3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-id-4-yl)diazenyl)-4-oxidophenyl)sulfonyl)amino)phenyl)diazenyl)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonate (1:3:2)
75234-42-3
1,1-Dimethylethyl N-[(1S,3S)-3-[hydroxy[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]carbamate
934841-33-5
(S)-6,7,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7,8-dihydrotetracene-5,12-dione
80948-70-5
Cuprate(2-), [4-[4-[2-[4-[2-[4,5-dihydro-3-methyl-1-(2-methyl-4-sulfophenyl)-5-oxo-1H-pyrazol-4-yl]diazenyl]-2-(hydroxy-kappaO)phenyl]diazenyl-kappaN1]-4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazol-1-yl]-3-methylbenzenesulfonato(4-)]-, sodium (1:2)
73297-24-2
Chromate(2-), [3-(hydroxy-kappaO)-4-[2-[2-(hydroxy-kappaO)-1-naphthalenyl]diazenyl-kappaN1]-7-nitro-1-naphthalenesulfonato(3-)][N-[7-(hydroxy-kappaO)-8-[2-[2-(hydroxy-kappaO)-4-nitrophenyl]diazenyl-kappaN1]-2-naphthalenyl]acetamidato(2-)]-, sodium (1:2)
73559-51-0
Cuprate(2-), [4-(hydroxy-kappaO)-3-[2-[2-(hydroxy-kappaO)-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl-kappaN1]-1-naphthalenesulfonato(4-)]-, potassium (1:2)
111239-50-0